Authors: Pantoja, A.¹; Lönnroth, K.¹; Lal, S.S.¹; Chauhan, L.S.²; Uplekar, M.¹; Padma, M.R.²; Unnikrishnan, K.P.³; Rajesh, J.³; Kumar, P.³; Sahu, S.¹; Wares, F.¹; Floyd, K.¹

Source: The International Journal of Tuberculosis and Lung Disease, Volume 13, Number 6, June 2009 , pp. 705-712(8)

Publisher: International Union Against Tuberculosis and Lung Disease

Abstract:

SETTING: Bangalore City, India.

OBJECTIVES: To assess the cost and cost-effectiveness of public-private mix (PPM) for tuberculosis (TB) care and control when implemented on a large scale.

DESIGN: DOTS implementation under the Revised National TB Control Programme (RNTCP) began in 1999, PPM was introduced in mid-2001 and a second phase of intensified PPM began in 2003. Data on the costs and effects of TB treatment from 1999 to 2005 were collected and used to compare the two distinct phases of PPM with a scenario of no PPM. Costs were assessed in 2005 $US for public and private providers, patients and patient attendants. Sources of data included expenditure records, medical records, interviews with staff and patient surveys. Effectiveness was measured as the number of cases successfully treated.

RESULTS: When PPM was implemented, total provider costs increased in proportion to the number of successfully treated TB cases. The average cost per patient treated from the provider perspective when PPM was implemented was stable, at US$69, in the intensified phase compared with US$71 pre-PPM. PPM resulted in the shift of an estimated 7200 patients from non-DOTS to DOTS treatment over 5 years. PPM implementation substantially reduced costs to patients, such that the average societal cost per patient successfully treated fell from US$154 to US$132 in the 4 years following the initiation of PPM.

CONCLUSION: Implementation of PPM on a large scale in an urban setting can be cost-effective, and considerably reduces the financial burden of TB for patients.

Keywords: cost-effectiveness; tuberculosis; public-private mix; India; patient costs

Document Type: Regular paper

Affiliations: 1: Stop TB Department, World Health Organization, Geneva, Switzerland 2: Revised National Tuberculosis Control Programme in India, Central TB Division, Ministry of Health and Family Welfare, New Delhi, India 3: National Tuberculosis Institute, Bangalore, India

Publication date: 2009-06-01

More about this publication?

• The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

  Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

• Editorial Board
• Information for Authors
• Subscribe to this Title
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine
• By this author: Pantoja, A. ;  Lönnroth, K. ;  Lal, S.S. ;  Chauhan, L.S. ;  Uplekar, M. ;  Padma, M.R. ;  Unnikrishnan, K.P. ;  Rajesh, J. ;  Kumar, P. ;  Sahu, S. ;  Wares, F. ;  Floyd, K.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers